Schmidt & Clark, LLP | A National Law Firm

Nationwide Darvocet® & Darvon® Recall Lawyer & Lawsuit


|


darvocet davron recall side effects heart attack lawyer lawsuit attorney class action settlement litigation claimFDA pulls Darvocet®, Davron® Pain Meds Off Market

 

Please note, Schmidt & Clark, LLP is no longer accepting Darvon or Darvocet claims.  If you feel that you may have a potential case, we urge you to locate another law firm adequately suited to handle your claim.

November 19, 2010 – According to an FDA announcement, Xanodyne Pharmaceuticals Inc. has agreed to withdraw its prescription pain medications Darvocet and Davron (Darvon N 100 mg) from the market. The FDA also asked generic makers of the pain medicine to voluntarily remove their products.

“The drug’s effectiveness in reducing pain is no longer enough to outweigh the drug’s serious potential heart risks,” the FDA said in today’s statement.

The move to recall comes after the drugs’ active ingredient propoxyphene was found to put patients at risk of potentially fatal heart rhythm abnormalities.

“We recommend to physicians stop prescribing the drugs. As for patients, do not stop taking it, but we urge you to contact your health care professional. Do not delay,” said Gerald Dal Pan, director of the FDA’s Office of Surveillance and Epidemiology.

FDA Discusses Ban on Darvon & Darvocet

Propoxyphene Warning

There have been numerous cases of accidental and intentional overdose with propoxyphene products either alone or in combination with other CNS depressants, including alcohol. Fatalities within the first hour of overdosage are not uncommon. Many of the propoxyphene-related deaths have occurred in patients with previous histories of emotional disturbances or suicidal ideation/attempts and/or concomitant administration of sedatives, tranquilizers, muscle relaxants, antidepressants, or other CNS-depressant drugs. Do not prescribe propoxyphene for patients who are suicidal or have a history of suicidal ideation.

Darvocet Side Effects? Contact us today.

The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Darvocet / Davron side effects injury lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.

Free Propoxyphene Recall Case Evaluation: If you or a loved one has been injured by either Darvocet, Davron, or any other medication containing propoxyphene, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

Attention Attorneys:  Schmidt & Clark considers a referral from another law firm to be one of the greatest compliments. Our law firm has built a reputation for success and accepts a number of case referrals on a regular basis. We do not publish prior verdicts or settlements on our website. If you would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please visit the attorney referral section of our website.